ITI Pharma and Healthcare Fund Regular vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹830 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 10 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 31% |
| Expense Ratio | 2.35 | 2.27 |
| Manager | Rohan Korde | Dhaval Joshi |
| ISIN Code | INF00XX01BL5 | INF209KB1N91 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | -0.35% | 1.26% |
| 6 Month | 2.13% | 6.15% |
| 1 Year | -1.33% | 4.35% |
| 3 Year | 18.98% | 21.36% |
| 5 Year | - | 15.83% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | -1.28% | 0.96% |
| 1 Year | 1.83% | 8.14% |
| 3 Year | 16.44% | 18.35% |
| 5 Year | - | 16.31% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 18.94% | 22.43% |
| 3 Year | 20.21% | 17.14% |
| 5 Year | - | 20.55% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 15.64% | 16.01% |
| Sharp | 0.77% | 0.85% |
| Beta | 0.95% | 0.96% |
| Alpha | -2.74% | -1.37% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Rohan Korde | Dhaval Joshi |
| Total AUM | ₹4626 Cr | ₹361932 Cr |
| Funds Managed | 10 | 55 |
| ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 3.56 | 4.88 |
| Large Cap | 29.45 | 25.69 |
| Mid Cap | 37.33 | 41.06 |
| Small Cap | 29.66 | 28.36 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 1.52 | 1.66 |
| Healthcare | 91.78 | 97.35 |
| Basic Materials | 3.67 | 0.99 |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | - |
Top Comparisons
Sundaram Aggressive Hybrid Fund (Formerly Known as Principal Hybrid Equity Fund)-Growth
3Y Returns12.55%
Edelweiss Aggressive Hybrid Fund - Regular Plan - Growth Option
3Y Returns16.81%
Franklin India Small Cap Fund-Growth
3Y Returns21.82%
HDFC Small Cap Fund Regular Growth
3Y Returns22.12%
Nippon India Medium to Long Duration Fund - Growth Plan - Growth Option
3Y Returns6.64%
UTI Medium to Long Duration Fund- Regular Plan - Growth
3Y Returns7.04%
Aditya Birla Sun Life Liquid Fund-Institutional (Growth)
3Y Returns7%
LIC MF Liquid Fund-Growth
3Y Returns6.94%